The entire replenishment of the Global Fund in 2013 is essential for donor-dependent countries.

APPG-GTB members express concern on the growing risk of multi-drug resistant TB In a Lancet Comment discussing the WHO Global Tuberculosis report 2013 published today [Wednesday 23 October], members of the united kingdom All-Party Parliamentary Group on Global Tuberculosis and lead author Professor Ali Zumla from University College London sound an alarm as the growing threat of multi-drug resistant TB to regional and global health security becomes more apparent. Additionally, the achievement rate of MDR-TB treatment remains below 50 percent due to high levels of death and losses to follow-up. The entire replenishment of the Global Fund in 2013 is essential for donor-dependent countries, since the Global Fund provides about three-quarters of worldwide donor financing for tuberculosis Read more ., a wholly possessed subsidiary of Fresenius Kabi Pharmaceuticals Keeping, Inc., announced today it received authorization from the U.S.